These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


163 related items for PubMed ID: 6133646

  • 1. Limitation of infarct size by beta blockers and its potential role for prognosis.
    Hjalmarson A, Herlitz J.
    Circulation; 1983 Jun; 67(6 Pt 2):I68-71. PubMed ID: 6133646
    [Abstract] [Full Text] [Related]

  • 2. Beta-adrenoceptor blockade and myocardial infarction: when should treatment start and for how long should it continue?
    Baber NS, Lewis JA.
    Circulation; 1983 Jun; 67(6 Pt 2):I71-7. PubMed ID: 6133647
    [Abstract] [Full Text] [Related]

  • 3. [Beta blockade in acute myocardial infarction].
    Bosković D, Terzić B, Perunicić J, Zugić M, Beleslin BD.
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():17-24. PubMed ID: 18196643
    [Abstract] [Full Text] [Related]

  • 4. [Necrotic lesions, ischemia and reperfusion: effects of beta blockers].
    Lechat P.
    Arch Mal Coeur Vaiss; 1993 Jul; 86 Spec No 4():85-90. PubMed ID: 7905729
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Influencing the prognosis of patients after myocardial infarct with the long-term administration of beta blockers].
    Málek I.
    Cas Lek Cesk; 1983 Nov 18; 122(46):1419-24. PubMed ID: 6140080
    [No Abstract] [Full Text] [Related]

  • 7. Benefits of non-selective versus cardioselective beta-blockers in acute myocardial infarction in hypertensive patients.
    Hansen O, Johansson BW.
    J Hypertens Suppl; 1993 Jun 18; 11(4):S55-60. PubMed ID: 8104242
    [Abstract] [Full Text] [Related]

  • 8. A review of ongoing trials of beta blockers in the secondary prevention of coronary heart disease.
    Cutler JA.
    Circulation; 1983 Jun 18; 67(6 Pt 2):I62-5. PubMed ID: 6133645
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
    Califf RM, Lokhnygina Y, Velazquez EJ, McMurray JJ, Leimberger JD, Lewis EF, Diaz R, Murin J, Pfeffer MA.
    Am J Cardiol; 2009 Jul 15; 104(2):151-7. PubMed ID: 19576338
    [Abstract] [Full Text] [Related]

  • 11. Using beta blockers after MI in the elderly.
    Danforth J, Ports TA.
    Geriatrics; 1985 May 15; 40(5):75-7, 80, 85. PubMed ID: 2859233
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Rest and the acutely ischaemic heart.
    Norris RM.
    N Z Med J; 1980 Jul 23; 92(664):53-6. PubMed ID: 6107887
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Myocardial infarction: secondary prevention with betablockers].
    Depelchin P, Hammoude H, Degré S.
    Ann Cardiol Angeiol (Paris); 1989 Mar 23; 38(3):155-61. PubMed ID: 2567590
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.